BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) Stock Fundamental Analysis

NASDAQ:BRKRP • US1167942077

305.21 USD
-1.46 (-0.48%)
Last: Feb 19, 2026, 08:00 PM
Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to BRKRP. BRKRP was compared to 58 industry peers in the Life Sciences Tools & Services industry. BRKRP has a medium profitability rating, but doesn't score so well on its financial health evaluation. BRKRP is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • BRKRP had positive earnings in the past year.
  • In the past year BRKRP had a positive cash flow from operations.
  • Of the past 5 years BRKRP 4 years were profitable.
  • BRKRP had a positive operating cash flow in each of the past 5 years.
BRKRP Yearly Net Income VS EBIT VS OCF VS FCFBRKRP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

1.2 Ratios

  • BRKRP has a Return On Assets of -0.36%. This is in the better half of the industry: BRKRP outperforms 63.79% of its industry peers.
  • BRKRP has a better Return On Equity (-0.91%) than 63.79% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 3.69%, BRKRP is in the better half of the industry, outperforming 68.97% of the companies in the same industry.
  • The Average Return On Invested Capital over the past 3 years for BRKRP is below the industry average of 12.04%.
Industry RankSector Rank
ROA -0.36%
ROE -0.91%
ROIC 3.69%
ROA(3y)3.88%
ROA(5y)5.49%
ROE(3y)12.15%
ROE(5y)17.79%
ROIC(3y)7.33%
ROIC(5y)9.58%
BRKRP Yearly ROA, ROE, ROICBRKRP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30

1.3 Margins

  • Looking at the Operating Margin, with a value of 6.74%, BRKRP is in the better half of the industry, outperforming 62.07% of the companies in the same industry.
  • In the last couple of years the Operating Margin of BRKRP has declined.
  • With a Gross Margin value of 46.70%, BRKRP perfoms like the industry average, outperforming 48.28% of the companies in the same industry.
  • In the last couple of years the Gross Margin of BRKRP has remained more or less at the same level.
Industry RankSector Rank
OM 6.74%
PM (TTM) N/A
GM 46.7%
OM growth 3Y-35.88%
OM growth 5Y-18.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.84%
GM growth 5Y-0.59%
BRKRP Yearly Profit, Operating, Gross MarginsBRKRP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40 50

2

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BRKRP is destroying value.
  • Compared to 1 year ago, BRKRP has about the same amount of shares outstanding.
  • BRKRP has about the same amout of shares outstanding than it did 5 years ago.
  • BRKRP has a better debt/assets ratio than last year.
BRKRP Yearly Shares OutstandingBRKRP Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M
BRKRP Yearly Total Debt VS Total AssetsBRKRP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • BRKRP has a debt to FCF ratio of 134.47. This is a negative value and a sign of low solvency as BRKRP would need 134.47 years to pay back of all of its debts.
  • BRKRP has a Debt to FCF ratio of 134.47. This is comparable to the rest of the industry: BRKRP outperforms 53.45% of its industry peers.
  • BRKRP has a Debt/Equity ratio of 0.75. This is a neutral value indicating BRKRP is somewhat dependend on debt financing.
  • BRKRP's Debt to Equity ratio of 0.75 is on the low side compared to the rest of the industry. BRKRP is outperformed by 77.59% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 134.47
Altman-Z N/A
ROIC/WACC0.34
WACC10.81%
BRKRP Yearly LT Debt VS Equity VS FCFBRKRP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.3 Liquidity

  • A Current Ratio of 1.73 indicates that BRKRP should not have too much problems paying its short term obligations.
  • BRKRP's Current ratio of 1.73 is on the low side compared to the rest of the industry. BRKRP is outperformed by 70.69% of its industry peers.
  • BRKRP has a Quick Ratio of 1.73. This is a bad value and indicates that BRKRP is not financially healthy enough and could expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 0.87, BRKRP is doing worse than 86.21% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.73
Quick Ratio 0.87
BRKRP Yearly Current Assets VS Current LiabilitesBRKRP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

  • BRKRP shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -24.07%.
  • BRKRP shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 6.27% yearly.
  • Looking at the last year, BRKRP shows a small growth in Revenue. The Revenue has grown by 2.08% in the last year.
  • Measured over the past years, BRKRP shows a quite strong growth in Revenue. The Revenue has been growing by 11.57% on average per year.
EPS 1Y (TTM)-24.07%
EPS 3Y-7.87%
EPS 5Y6.27%
EPS Q2Q%-22.37%
Revenue 1Y (TTM)2.08%
Revenue growth 3Y10.74%
Revenue growth 5Y11.57%
Sales Q2Q%-0.24%

3.2 Future

  • Based on estimates for the next years, BRKRP will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.20% on average per year.
  • The Revenue is expected to grow by 3.22% on average over the next years.
EPS Next Y19.49%
EPS Next 2Y16.71%
EPS Next 3Y14.62%
EPS Next 5Y12.2%
Revenue Next Year4.16%
Revenue Next 2Y4.07%
Revenue Next 3Y4.4%
Revenue Next 5Y3.22%

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BRKRP Yearly Revenue VS EstimatesBRKRP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B 4B
BRKRP Yearly EPS VS EstimatesBRKRP Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

2

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 166.78 indicates a quite expensive valuation of BRKRP.
  • The rest of the industry has a similar Price/Earnings ratio as BRKRP.
  • When comparing the Price/Earnings ratio of BRKRP to the average of the S&P500 Index (26.99), we can say BRKRP is valued expensively.
  • Based on the Price/Forward Earnings ratio of 139.57, the valuation of BRKRP can be described as expensive.
  • BRKRP's Price/Forward Earnings ratio is in line with the industry average.
  • When comparing the Price/Forward Earnings ratio of BRKRP to the average of the S&P500 Index (28.06), we can say BRKRP is valued expensively.
Industry RankSector Rank
PE 166.78
Fwd PE 139.57
BRKRP Price Earnings VS Forward Price EarningsBRKRP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

  • BRKRP's Enterprise Value to EBITDA is on the same level as the industry average.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of BRKRP is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 3336.23
EV/EBITDA 106.07
BRKRP Per share dataBRKRP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 -5 10 15 20

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • BRKRP's earnings are expected to grow with 14.62% in the coming years. This may justify a more expensive valuation.
PEG (NY)8.56
PEG (5Y)26.59
EPS Next 2Y16.71%
EPS Next 3Y14.62%

3

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.52%, BRKRP is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.10, BRKRP pays a better dividend. On top of this BRKRP pays more dividend than 91.38% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.85, BRKRP's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.52%

5.2 History

  • The dividend of BRKRP is nicely growing with an annual growth rate of 6.16%!
  • BRKRP is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)6.16%
Div Incr YearsN/A
Div Non Decr YearsN/A
BRKRP Yearly Dividends per shareBRKRP Yearly Dividends per shareYearly Dividends per share 2025 2026 1 2 3

5.3 Sustainability

  • The earnings of BRKRP are negative and hence is the payout ratio. BRKRP will probably not be able to sustain this dividend level.
  • The dividend of BRKRP is growing, but earnings are growing more, so the dividend growth is sustainable.
DP-146.22%
EPS Next 2Y16.71%
EPS Next 3Y14.62%
BRKRP Yearly Income VS Free CF VS DividendBRKRP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M 400M

BRUKER CORP - BRKR 6 3/8 09/01/28

NASDAQ:BRKRP (2/19/2026, 8:00:02 PM)

305.21

-1.46 (-0.48%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)02-12
Earnings (Next)05-05
Inst Owners90.2%
Inst Owner ChangeN/A
Ins Owners26.95%
Ins Owner ChangeN/A
Market Cap46.37B
Revenue(TTM)3.44B
Net Income(TTM)-22.50M
Analysts79.09
Price Target429.32 (40.66%)
Short Float %0.04%
Short Ratio2.34
Dividend
Industry RankSector Rank
Dividend Yield 0.52%
Yearly Dividend0.22
Dividend Growth(5Y)6.16%
DP-146.22%
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-Date02-13
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.4%
Min EPS beat(2)-10.9%
Max EPS beat(2)31.69%
EPS beat(4)2
Avg EPS beat(4)0.34%
Min EPS beat(4)-26.01%
Max EPS beat(4)31.69%
EPS beat(8)4
Avg EPS beat(8)1.39%
EPS beat(12)8
Avg EPS beat(12)4.7%
EPS beat(16)11
Avg EPS beat(16)5.48%
Revenue beat(2)0
Avg Revenue beat(2)-0.45%
Min Revenue beat(2)-0.6%
Max Revenue beat(2)-0.29%
Revenue beat(4)1
Avg Revenue beat(4)-0.44%
Min Revenue beat(4)-3.65%
Max Revenue beat(4)2.76%
Revenue beat(8)1
Avg Revenue beat(8)-1.04%
Revenue beat(12)5
Avg Revenue beat(12)0.47%
Revenue beat(16)8
Avg Revenue beat(16)0.64%
PT rev (1m)7.26%
PT rev (3m)18.49%
EPS NQ rev (1m)0.78%
EPS NQ rev (3m)-6.3%
EPS NY rev (1m)0.28%
EPS NY rev (3m)-3.71%
Revenue NQ rev (1m)0.26%
Revenue NQ rev (3m)-0.64%
Revenue NY rev (1m)0.06%
Revenue NY rev (3m)-0.6%
Valuation
Industry RankSector Rank
PE 166.78
Fwd PE 139.57
P/S 13.49
P/FCF 3336.23
P/OCF 345.81
P/B 18.75
P/tB N/A
EV/EBITDA 106.07
EPS(TTM)1.83
EY0.6%
EPS(NY)2.19
Fwd EY0.72%
FCF(TTM)0.09
FCFY0.03%
OCF(TTM)0.88
OCFY0.29%
SpS22.62
BVpS16.28
TBVpS-5.33
PEG (NY)8.56
PEG (5Y)26.59
Graham Number25.89
Profitability
Industry RankSector Rank
ROA -0.36%
ROE -0.91%
ROCE 4.67%
ROIC 3.69%
ROICexc 3.93%
ROICexgc 13.27%
OM 6.74%
PM (TTM) N/A
GM 46.7%
FCFM 0.4%
ROA(3y)3.88%
ROA(5y)5.49%
ROE(3y)12.15%
ROE(5y)17.79%
ROIC(3y)7.33%
ROIC(5y)9.58%
ROICexc(3y)8.28%
ROICexc(5y)12.88%
ROICexgc(3y)16.23%
ROICexgc(5y)22.02%
ROCE(3y)9.28%
ROCE(5y)12.13%
ROICexgc growth 3Y-29.97%
ROICexgc growth 5Y-15.3%
ROICexc growth 3Y-45.99%
ROICexc growth 5Y-27.41%
OM growth 3Y-35.88%
OM growth 5Y-18.65%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.84%
GM growth 5Y-0.59%
F-Score4
Asset Turnover0.55
Health
Industry RankSector Rank
Debt/Equity 0.75
Debt/FCF 134.47
Debt/EBITDA 4.1
Cap/Depr 54.56%
Cap/Sales 3.5%
Interest Coverage 250
Cash Conversion 29.67%
Profit Quality N/A
Current Ratio 1.73
Quick Ratio 0.87
Altman-Z N/A
F-Score4
WACC10.81%
ROIC/WACC0.34
Cap/Depr(3y)70.11%
Cap/Depr(5y)91.82%
Cap/Sales(3y)3.51%
Cap/Sales(5y)3.89%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-24.07%
EPS 3Y-7.87%
EPS 5Y6.27%
EPS Q2Q%-22.37%
EPS Next Y19.49%
EPS Next 2Y16.71%
EPS Next 3Y14.62%
EPS Next 5Y12.2%
Revenue 1Y (TTM)2.08%
Revenue growth 3Y10.74%
Revenue growth 5Y11.57%
Sales Q2Q%-0.24%
Revenue Next Year4.16%
Revenue Next 2Y4.07%
Revenue Next 3Y4.4%
Revenue Next 5Y3.22%
EBIT growth 1Y-40.13%
EBIT growth 3Y-29%
EBIT growth 5Y-9.23%
EBIT Next Year50.4%
EBIT Next 3Y20.22%
EBIT Next 5Y17.98%
FCF growth 1Y-89.78%
FCF growth 3Y-54.25%
FCF growth 5Y-43.19%
OCF growth 1Y-46.64%
OCF growth 3Y-21.23%
OCF growth 5Y-16.59%

BRUKER CORP - BRKR 6 3/8 09/01/28 / BRKRP FAQ

What is the fundamental rating for BRKRP stock?

ChartMill assigns a fundamental rating of 3 / 10 to BRKRP.


What is the valuation status of BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) stock?

ChartMill assigns a valuation rating of 2 / 10 to BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP). This can be considered as Overvalued.


How profitable is BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) stock?

BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) has a profitability rating of 4 / 10.


What is the expected EPS growth for BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) stock?

The Earnings per Share (EPS) of BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) is expected to grow by 19.49% in the next year.


Can you provide the dividend sustainability for BRKRP stock?

The dividend rating of BRUKER CORP - BRKR 6 3/8 09/01/28 (BRKRP) is 3 / 10 and the dividend payout ratio is -146.22%.